Expanding global access to radiotherapy
Radiotherapy is a critical and inseparable component of comprehensive cancer treatment
and care. For many of the most common cancers in low-income and middle-income …
and care. For many of the most common cancers in low-income and middle-income …
[HTML][HTML] The known unknowns of HPV natural history
PE Gravitt - The Journal of clinical investigation, 2011 - Am Soc Clin Investig
The discovery that certain high-risk strains of human papillomavirus (HR-HPV) cause nearly
100% of invasive cervical cancer has spurred a revolution in cervical cancer prevention by …
100% of invasive cervical cancer has spurred a revolution in cervical cancer prevention by …
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
Background Vaccination against the most common oncogenic human papillomavirus (HPV)
types, HPV-16 and HPV-18, could prevent development of up to 70% of cervical cancers …
types, HPV-16 and HPV-18, could prevent development of up to 70% of cervical cancers …
[HTML][HTML] Sustained efficacy up to 4· 5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised …
Background Effective vaccination against HPV 16 and HPV 18 to prevent cervical cancer will
require a high level of sustained protection against infection and precancerous lesions. Our …
require a high level of sustained protection against infection and precancerous lesions. Our …
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors
Abstract The American Cancer Society (ACS) has developed guidelines for the use of the
prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical …
prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical …
[HTML][HTML] Prevention of cervical cancer through papillomavirus vaccination
IH Frazer - Nature Reviews Immunology, 2004 - nature.com
A subset of human papillomaviruses (HPVs) promote anogenital malignancy, including
cervical cancer, and prevention and treatment strategies that reflect the causal role of HPV …
cervical cancer, and prevention and treatment strategies that reflect the causal role of HPV …
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
Background: Human papillomavirus (HPV) vaccine may be commercially available in a few
years. We explored the clinical benefits and cost-effectiveness of introducing an HPV16/18 …
years. We explored the clinical benefits and cost-effectiveness of introducing an HPV16/18 …
Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial
L Denny, L Kuhn, M De Souza, AE Pollack, W Dupree… - Jama, 2005 - jamanetwork.com
ContextNon–cytology-based screen-and-treat approaches for cervical cancer prevention
have been developed for low-resource settings, but few have directly addressed efficacy …
have been developed for low-resource settings, but few have directly addressed efficacy …
Human papillomavirus in cervical and head-and-neck cancer
Cervical cancer is a major cause of cancer mortality in women worldwide and is initiated by
infection with high-risk human papillomaviruses (HPVs). High-risk HPVs, especially HPV-16 …
infection with high-risk human papillomaviruses (HPVs). High-risk HPVs, especially HPV-16 …
Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control
Universal deployment of organized or opportunistic screening with Pap cytology in high and
middle income countries has been the primary reason for the substantial reductions in …
middle income countries has been the primary reason for the substantial reductions in …